Plant-Derived Terpenes as Emerging Therapeutics Against Schistosomiasis
International Journal of Molecular Sciences · 26.05.2026 · 27 (11) · 4799
DOI: 10.3390/ijms27114799 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.05.2026. Verfasst von Célia Faustino und 2 weiteren Autor:innen. Beteiligte Einrichtung: iMed.ULisboa, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Avenida Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Hauptthemen laut MEDLINE: Terpenes, Schistosomiasis, Schistosoma, Schistosomicides. Die Arbeit nennt 343 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Schistosomiasis remains one of the most significant neglected tropical diseases (NTDs) worldwide, sustained by the complex biology of Schistosoma species and the host’s immunopathological responses to tissue-trapped eggs. Despite decades of reliance on praziquantel (PZQ) as the sole chemotherapeutic option, major limitations persist, including its lack of activity against juvenile worms, incomplete protection against reinfection, and concerns regarding emerging tolerance. These challenges, together with persistent hotspots of transmission and uneven global progress toward disease elimination, underscore the urgent need for alternative or complementary therapies. Plant-derived terpenes have emerged as promising antischistosomal candidates due to their structural diversity, broad-spectrum bioactivity, and favourable safety profiles. Evidence from in vitro and in vivo studies demonstrates that monoterpenes, sesquiterpenes, diterpenes, triterpenes, and triterpenoid saponins exert multimodal effects on Schistosoma, including tegumental disruption, interference with metabolic and redox pathways, inhibition of oviposition, and modulation of host immune and fibrotic responses. Advances in mechanistic studies, supported by omics and computational approaches, further highlight their potential as leads for drug development. Additionally, nano-enabled delivery systems offer strategies to overcome pharmacokinetic limitations and enhance therapeutic performance. This review integrates current knowledge on schistosome biology, treatment challenges, and the growing evidence supporting terpenoids as viable components of a diversified antischistosomal therapeutic arsenal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- iMed.ULisboa, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Avenida Prof. Gama Pinto, 1649-003 Lisbon, Portugal.
ORCID-Profile: Célia Faustino, Lídia Pinheiro, Noélia Duarte
Zitieren
APA
Faustino, C., Pinheiro, L., & Duarte, N. (2026). Plant-Derived Terpenes as Emerging Therapeutics Against Schistosomiasis. International Journal of Molecular Sciences, 27(11), 4799. https://doi.org/10.3390/ijms27114799
Vancouver
Faustino C, Pinheiro L, Duarte N. Plant-Derived Terpenes as Emerging Therapeutics Against Schistosomiasis. International Journal of Molecular Sciences. 2026;27(11):4799. doi:10.3390/ijms27114799
BibTeX
@article{Faustino2026,
author = {Faustino, Célia and Pinheiro, Lídia and Duarte, Noélia},
title = {Plant-Derived Terpenes as Emerging Therapeutics Against Schistosomiasis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4799},
doi = {10.3390/ijms27114799}
}
EUVIMED